Heffernan Michael Thomas
Director
Latest Insider Transactions
Showing 10 of 11 transactions (past 365 days)
| 2026-09-17 | 2026-09-15 | TRVI Trevi Therapeutics, Inc. | Director | Sale | 20,952 | $15.09 | $316,166 |
| 2026-09-17 | 2026-09-15 | TRVI Trevi Therapeutics, Inc. | Director | Sale | 100 | $15.88 | $1,588 |
| 2026-09-17 | 2026-09-15 | TRVI Trevi Therapeutics, Inc. | Director | Exercise Conversion | 18,421 | $3.04 | $56,000 |
| 2026-09-17 | 2026-09-15 | TRVI Trevi Therapeutics, Inc. | Director | Exercise Conversion | 18,421 | $3.04 | $56,000 |
| 2026-09-17 | 2026-09-15 | TRVI Trevi Therapeutics, Inc. | Director | Exercise Conversion | 21,052 | $3.33 | $70,103 |
| 2026-09-17 | 2026-09-15 | TRVI Trevi Therapeutics, Inc. | Director | Exercise Conversion | 21,052 | $3.33 | $70,103 |
| 2026-09-17 | 2026-09-15 | TRVI Trevi Therapeutics, Inc. | Director | Sale | 18,321 | $15.09 | $276,464 |
| 2026-06-17 | 2026-06-16 | ENGN Engene Therapeutics Inc. | Director | Award | 31,000 | $1.75 | $54,250 |
| 2026-06-04 | 2026-06-02 | AVTX Avalo Therapeutics, Inc. | Director | Award | 29,500 | $13.96 | $411,820 |
| 2026-06-04 | 2026-06-03 | TRVI Trevi Therapeutics, Inc. | Director | Award | 35,000 | $13.45 | $470,750 |
TRVI
Director
Sale
$316.2K
20,952 shares @ $15.09
Filed 2026-09-17Trade 2026-09-15
Trevi Therapeutics, Inc.TRVI
Director
Exercise Conversion
$56K
18,421 shares @ $3.04
Filed 2026-09-17Trade 2026-09-15
Trevi Therapeutics, Inc.TRVI
Director
Exercise Conversion
$56K
18,421 shares @ $3.04
Filed 2026-09-17Trade 2026-09-15
Trevi Therapeutics, Inc.TRVI
Director
Exercise Conversion
$70.1K
21,052 shares @ $3.33
Filed 2026-09-17Trade 2026-09-15
Trevi Therapeutics, Inc.TRVI
Director
Exercise Conversion
$70.1K
21,052 shares @ $3.33
Filed 2026-09-17Trade 2026-09-15
Trevi Therapeutics, Inc.TRVI
Director
Sale
$276.5K
18,321 shares @ $15.09
Filed 2026-09-17Trade 2026-09-15
Trevi Therapeutics, Inc.ENGN
Director
Award
$54.3K
31,000 shares @ $1.75
Filed 2026-06-17Trade 2026-06-16
Engene Therapeutics Inc.AVTX
Director
Award
$411.8K
29,500 shares @ $13.96
Filed 2026-06-04Trade 2026-06-02
Avalo Therapeutics, Inc.TRVI
Director
Award
$470.8K
35,000 shares @ $13.45
Filed 2026-06-04Trade 2026-06-03
Trevi Therapeutics, Inc.Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.